期刊文献+
共找到50篇文章
< 1 2 3 >
每页显示 20 50 100
Glycogen Synthase Kinase-3β,NLRP3 Inflammasome,and Alzheimer's Disease 被引量:1
1
作者 Yue-ran JIA Zi-qing GUO +1 位作者 Qian GUO Xiao-chuan WANG 《Current Medical Science》 SCIE CAS 2023年第5期847-854,共8页
Alzheimer’s disease (AD) is the most prevalent cause of dementia worldwide. Because of the progressive neurodegeneration, individual cognitive and behavioral functions are impaired, affecting the quality of life of m... Alzheimer’s disease (AD) is the most prevalent cause of dementia worldwide. Because of the progressive neurodegeneration, individual cognitive and behavioral functions are impaired, affecting the quality of life of millions of people. Although the exact pathogenesis of AD has not been fully elucidated, amyloid plaques, neurofibrillary tangles (NFTs), and sustaining neuroinflammation dominate its characteristics. As one of the major tau kinases leading to hyperphosphorylation and aggregation of tau, glycogen synthase kinase-3β (GSK-3β) has been drawing great attention in various AD studies. Another research focus of AD in recent years is the inflammasome, a multiprotein complex acting as a regulator in immunological reactions to exogenous and endogenous danger signals, of which the Nod-like receptor (NLR) family, pyrin domain-containing 3 (NLRP3) inflammasome has been studied mostly in AD and proven to play a significant role in AD development by its activation and downstream effects such as caspase-1 maturation and interleukin (IL)-1β release. Studies have shown that the NLRP3 inflammasome is activated in a GSK-3β-dependent way and that inhibition of the NLRP3 inflammasome downregulates GSK-3β, suggesting that these two important proteins are closely related. This article reviews the respective roles of GSK-3β and the NLRP3 inflammasome in AD as well as their relationship and interaction. 展开更多
关键词 glycogen synthase kinase-3β NLRP3 inflammasome Alzheimer's disease
下载PDF
Cornel iridoid glycoside induces autophagy to protect against tau oligomer neurotoxicity induced by activation of glycogen synthase kinase-3β 被引量:4
2
作者 YANG Cui-cui LI Xue-lian +3 位作者 ZHANG Li LI Ya-li LI Lin ZHANG Lan 《中国药理学与毒理学杂志》 CAS 北大核心 2019年第6期456-456,共1页
Tau oligomers are the etiologic molecules of Alzheimer disease(AD), and correlate strongly with neuronal loss and exhibit neurotoxicity. Recent evidence indicates that small tau oligomers are the most relevant toxic a... Tau oligomers are the etiologic molecules of Alzheimer disease(AD), and correlate strongly with neuronal loss and exhibit neurotoxicity. Recent evidence indicates that small tau oligomers are the most relevant toxic aggregate species. The aim of the present study was to investigate the mechanisms of cornel iridoid glycoside(CIG) on tau oligomers and cognitive functions. We injected wortmannin and GF-109203 X(WM/GFX, 200 μmol·L-1 each) into the lateral ventricles to induce tau oligomer and memory impairment in rats. When oral y administered with CIG at 60 and 120 mg·kg-1 per day for 14 d, CIG decreased the escape latency in Morris water maze test. We also found that CIG restored the expression of presynaptic p-synapsin, synaptophysin, and postsynaptic density-95(PSD-95) decreased by WM/GFX in rat cortex. CIG reduced the accumulation of tau oligomers in the brain of WM/GFX rats and in cells transfected with wild type glycogen synthase kinase-3β(wt GSK-3β). In addition, CIG up-regulated the levels of ATG7, ATG12, Beclin-1, and LC3 II in vivo and in vitro, suggesting the restoration of autophagy function. These results suggest that CIG could ameliorate memory deficits and regulate memory-associated synaptic proteins through the clearance of tau oligomers accumulation. Moreover, CIG clears tau oligomers by restoring autophagy function. 展开更多
关键词 cornel IRIDOID GLYCOSIDE AUTOPHAGY TAU OLIGOMER glycogen synthase kinase-3β
下载PDF
The Akt/glycogen synthase kinase-3β pathway participates in the neuroprotective effect of interleukin-4 against cerebral ischemia/reperfusion injury 被引量:4
3
作者 Mei Li Wen-Wei Gao +4 位作者 Lian Liu Yue Gao Ya-Feng Wang Bo Zhao Xiao-Xing Xiong 《Neural Regeneration Research》 SCIE CAS CSCD 2020年第9期1716-1723,共8页
Interleukin-4(IL-4) has a protective effect against cerebral ischemia/reperfusion injury. Animal experiments have shown that IL-4 improves the short-and long-term prognosis of neurological function. The Akt(also calle... Interleukin-4(IL-4) has a protective effect against cerebral ischemia/reperfusion injury. Animal experiments have shown that IL-4 improves the short-and long-term prognosis of neurological function. The Akt(also called protein kinase B, PKB)/glycogen synthase kinase-3β(Akt/GSK-3β) signaling pathway is involved in oxidative stress, the inflammatory response, apoptosis, and autophagy. However, it is not yet clear whether the Akt/GSK-3β pathway participates in the neuroprotective effect of IL-4 against cerebral ischemia/reperfusion injury. In the present study, we established a cerebral ischemia/reperfusion mouse model by middle cerebral artery occlusion for 60 minutes followed by a 24-hour reperfusion. An IL-4/anti-IL-4 complex(10 μg) was intraperitoneally administered 30 minutes before surgery. We found that administration of IL-4 significantly alleviated the neurological deficits, oxidative stress, cell apoptosis, and autophagy and reduced infarct volume of the mice with cerebral ischemia/reperfusion injury 24 hours after reperfusion. Simultaneously, IL-4 activated Akt/GSK-3β signaling pathway. However, an Akt inhibitor LY294002, which was injected at 15 nmol/kg via the tail vein, attenuated the protective effects of IL-4. These findings indicate that IL-4 has a protective effect on cerebral ischemia/reperfusion injury by mitigating oxidative stress, reducing apoptosis, and inhibiting excessive autophagy, and that this mechanism may be related to activation of the Akt/GSK-3β pathway. This animal study was approved by the Animal Ethics Committee of Renmin Hospital of Wuhan University, China(approval No. WDRY2017-K037) on March 9, 2017. 展开更多
关键词 Akt/glycogen synthase kinase-3βpathway apoptosis autophagy cerebral ischemia/reperfusion injury infarct volume INTERLEUKIN-4 NEUROPROTECTION oxidative stress
下载PDF
Ischemic postconditioning enhances glycogen synthase kinase-3β expression and alleviates cerebral ischemia/reperfusion injury 被引量:2
4
作者 Bo Zhao Wenwei Gao +2 位作者 Jiabao Hou Yang Wu Zhongyuan Xia 《Neural Regeneration Research》 SCIE CAS CSCD 2012年第19期1507-1512,共6页
The present study established global brain ischemia using the four-vessel occlusion method. Following three rounds of reperfusion for 30 seconds, and occlusion for 10 seconds, followed by reperfusion for 48 hours, inf... The present study established global brain ischemia using the four-vessel occlusion method. Following three rounds of reperfusion for 30 seconds, and occlusion for 10 seconds, followed by reperfusion for 48 hours, infarct area, the number of TUNEL-positive cells and Bcl-2 expression were significantly reduced. However, glycogen synthase kinase-3β activity, cortical Bax and caspase-3 expression significantly increased, similar to results following ischemic postconditioning. Our results indicated that ischemic postconditioning may enhance glycogen synthase kinase-3β activity, a downstream molecule of the phosphatase and tensin homolog deleted on chromosome 10/phosphatidylinositol 3-kinase/protein kinase B signaling pathway, which reduces caspase-3 expression to protect the brain against ischemic injury. 展开更多
关键词 cerebral ischemia/reperfusion glycogen synthase kinase-3β ischemic postconditioning ISCHEMICPRECONDITIONING APOPTOSIS neural regeneration
下载PDF
1-methyl-4-phenylpyridinium ion induces endoplasmic reticulum stress through glycogen synthase kinase-3 beta activation in PC12 cells 被引量:1
5
作者 Shengdong Wang Fucheng Luo Yan Chen Lei Qi Jie Bai 《Neural Regeneration Research》 SCIE CAS CSCD 2011年第11期805-810,共6页
1-methyl-4-phenylpyridinium ion (MPP^+) induces endoplasmic reticulum stress and activates caspase-12 in PC12 cells, leading to neuronal apoptosis. However, the underlying molecular mechanism remains unknown. The p... 1-methyl-4-phenylpyridinium ion (MPP^+) induces endoplasmic reticulum stress and activates caspase-12 in PC12 cells, leading to neuronal apoptosis. However, the underlying molecular mechanism remains unknown. The present study investigated the regulatory effects of nerve growth factor (Akt activator) and lithium chloride (glycogen synthase kinase-3β inhibitor) on the endoplasmic reticulum stress signaling pathway. The results revealed that MPP+ induced expression of Bip and C/EBP homologous protein. The upregulation of Bip and C/EBP homologous protein, as well as the decreased pro-caspase-12 level induced by MPP^+ were inhibited by pretreatment of the nerve growth factor or lithium chloride. These results suggest that the phosphatidylinositol 3 kinase-Aktglycogen synthase kinase-3β pathway is involved in MPP-induced endoplasmic reticulum stress. 展开更多
关键词 Parkinson's disease 1-methyl-4-phenylpyridinium ion endoplasmic reticulum stress glycogen synthase kinase-3β
下载PDF
Regenerative potential of targeting glycogen synthase kinase-3 signaling in neural tissues
6
作者 Eui-Man Jung Jeffrey J.Moffat Woo-Yang Kim 《Neural Regeneration Research》 SCIE CAS CSCD 2015年第12期1912-1913,共2页
Multiple roles of glycogen synthase kinase-3(GSK-3)in neural tissues:GSK-3 is a serine/threonine kinase that has two isoforms encoded by two different genes,GSK-3αand GSK-3β,in mammals.GSK-3 has several sites of ... Multiple roles of glycogen synthase kinase-3(GSK-3)in neural tissues:GSK-3 is a serine/threonine kinase that has two isoforms encoded by two different genes,GSK-3αand GSK-3β,in mammals.GSK-3 has several sites of serine and tyrosine phosphorylation. 展开更多
关键词 GSK Regenerative potential of targeting glycogen synthase kinase-3 signaling in neural tissues
下载PDF
Molecular docking study of xylogranatins binding to glycogen synthase kinase-3β
7
作者 Christian Baillya Gérard Vergoten 《Digital Chinese Medicine》 2022年第1期9-17,共9页
Objective The mangrove tree Xylocarpus granatum J.Koenig(X.granatum)is a medicinal plant used to treat various diseases in several Asian countries.Many bioactive natural products have been isolated from the plants,par... Objective The mangrove tree Xylocarpus granatum J.Koenig(X.granatum)is a medicinal plant used to treat various diseases in several Asian countries.Many bioactive natural products have been isolated from the plants,particularly several groups of limonoids,including 18 xylogranatins(Xyl-A to R),all of which bear a furyl-δ-lactone core commonly found in limonoids.Based on a structural analogy with the limonoids obacunone and gedunin,we hypothesized that xylogranatins could target the enzyme glycogen synthase kinase-3β(GSK-3β),a major target for the treatment of neurodegenerative pathologies,viral infections,and cancers.Methods We investigated the binding of the 18 xylogranatins to GSK-3βusing molecular docking in comparison with two known reference GSK-3βATP-competitive inhibitors,LY2090314 and AR-A014418.For each compound bound to GSK-3β,the empirical energy of interaction(ΔE)was calculated and compared to that obtained with known GSK-3βinhibitors and limonoid triterpenes that target this enzyme.Results Five compounds were identified as potential GSK-3βbinders,Xyl-A,-C,-J,-N,and-O,for which the calculated empiricalΔE was equivalent to that calculated using the best reference molecule AR-A014418.The best ligand is Xyl-C,which is known to have marked anticancer properties.Binding of Xyl-C to the ATP-binding pocket of GSK-3βpositions the furyl-δ-lactone unit deep into the binding-site cavity.Other xylogranatin derivatives bearing a central pyridine ring or a compact polycyclic structure are much less adapted for GSK-3βbinding.Structure-binding relationships are discussed.Conclusion GSK-3βmay contribute to the anticancer effects of X.granatum extract.This study paves the way for the identification of other furyl-δ-lactone-containing limonoids as GSK-3βmodulators. 展开更多
关键词 Natural products Xylocarpus granatum Xylogranatins glycogen synthase kinase-3β(GSK-3β) LIMONOIDS CANCER Molecular modelling Structure-activity relationship
下载PDF
GSK3β inhibitor promotes myelination and mitigates muscle atrophy after peripheral nerve injury 被引量:9
8
作者 Jian Weng Yan-hua Wang +2 位作者 Ming Li Dian-ying Zhang Bao-guo Jiang 《Neural Regeneration Research》 SCIE CAS CSCD 2018年第2期324-330,共7页
Delay of axon regeneration after peripheral nerve injury usually leads to progressive muscle atrophy and poor functional recovery. The Wnt/β-catenin signaling pathway is considered to be one of the main molecular mec... Delay of axon regeneration after peripheral nerve injury usually leads to progressive muscle atrophy and poor functional recovery. The Wnt/β-catenin signaling pathway is considered to be one of the main molecular mechanisms that lead to skeletal muscle atrophy in the elderly. We hold the hypothesis that the innervation of target muscle can be promoted by accelerating axon regeneration and decelerating muscle cell degeneration so as to improve functional recovery of skeletal muscle following peripheral nerve injury. This process may be associated with the Wnt/β-catenin signaling pathway. Our study designed in vitro cell models to simulate myelin regeneration and muscle atrophy. We investigated the effects of SB216763, a glycogen synthase kinase 3 beta inhibitor, on the two major murine cell lines RSC96 and C2C12 derived from Schwann cells and muscle satellite cells. The results showed that SB216763 stimulated the Schwann cell migra- tion and myotube contraction. Quantitative polymerase chain reaction results demonstrated that myelin related genes, myelin associated glycoprotein and cyclin-D1, muscle related gene myogenin and endplate-associated gene nicotinic acetylcholine receptors levels were stimulated by SB216763. Immunocytochemical staining revealed that the expressions of ^-catenin in the RSC96 and C2C12 cytosolic and nuclear compartments were increased in the SB216763-treated cells. These findings confirm that the glycogen synthase kinase 3 beta in- hibitor, SB216763, promoted the myelination and myotube differentiation through the Wnt/β-catenin signaling pathway and contributed to nerve remyelination and reduced denervated muscle atrophy after peripheral nerve injury. 展开更多
关键词 nerve regeneration glycogen synthase kinase 3 beta inhibitor SB216763 MYELINATION myotube differentiation denervated muscle atrophy Wnt/^-catenin Schwann cell muscle cells peripheral nerve injury neural regeneration
下载PDF
Construction of the Pharmacophore Model of Glycogen Synthase Kinase-3 Inhibitors 被引量:1
9
作者 刘玲 张丽娜 姜凤超 《Chinese Journal of Chemistry》 SCIE CAS CSCD 2007年第7期892-897,共6页
A three dimensional pharmacophore model has been generated for glycogen synthase kinase-3 (GSK-3) inhibitots. A dataset consisting of 89 compounds was selected on the basis of the information content of the structur... A three dimensional pharmacophore model has been generated for glycogen synthase kinase-3 (GSK-3) inhibitots. A dataset consisting of 89 compounds was selected on the basis of the information content of the structures and activity data as required by the CATALYST system. The optimum model with four features (one hydrogen-bond acceptor unit, one ring aromatic unit, and two hydrophobic aromatic units) was selected with a good correlation coefficient (0.95). This model is able to predict the activity of other known GSK-3 inhibitors not included in the model generation, and can be further used to identify structurally diverse compounds with desired biological activity by virtual screening. 展开更多
关键词 glycogen synthase kinase-3 glycogen synthase kinase-3 inhibitor PHARMACOPHORE
原文传递
Chinese Prescription Kangen-karyu as Potential Anti-Alzheimer’s Disease Therapeutic:Analyses of BACE1 and GSK-3βInhibitory Activities
10
作者 Chan Hum Park Min Jo Kim +3 位作者 Hyun Ah Jung Jae Sue Choi Jin Pyeong Jeon Takako Yokozawa 《Journal of Integrative Medicine(双语)》 2021年第2期37-42,共6页
Inhibition ofβ-site amyloid precursor protein-cleaving enzyme 1(BACE1)or glycogen synthase kinase-3β(GSK-3β)is estimated to be the central therapeutic approach for Alzheimer’s disease(AD).In this study,water extra... Inhibition ofβ-site amyloid precursor protein-cleaving enzyme 1(BACE1)or glycogen synthase kinase-3β(GSK-3β)is estimated to be the central therapeutic approach for Alzheimer’s disease(AD).In this study,water extract of Kangenkaryu,its crude drug and chemical composition used in oriental medicine were evaluated regarding their BACE1 and GSK-3βinhibitory activities.Fluorescence resonance energy transfer was used to characterize the BACE1 inhibitory effect of Kangen-karyu,its crude drug and chemical composition.GSK-3βactivity was determined using the Kinase-Glo Luminescent Kinase Assay Platform.The water extract of Kangen-karyu inhibited BACE1 and GSK-3βin concentration-dependent manners when compared with reference drugs,quercetin and luteolin.Among six components of Kangen-karyu,the water extracts of Salviae Miltiorrhizae Radix or Cyperi Rhizoma exhibited significant inhibitory effects on BACE1 and GSK-3β.Among the constituents of Salviae Miltiorrhizae Radix extract,salvianolic acid C,salvianolic acid A,rosmarinic acid,and magnesium lithospermate B significantly inhibited BACE1.In addition,they inhibited GSK-3βwith an IC50 value range of 6.97 to 135.35μM.From these results,one of the effectiveness and its mechanisms of action of Kangen-karyu against AD may be the inhibition of BACE1 and GSK-3β,and one of the active ingredients of Kangen-karyu is Salviae Miltiorrhizae Radix and its constituents. 展开更多
关键词 Alzheimer’s disease β-Site amyloid precursor protein-cleaving enzyme 1 glycogen synthase kinase-3β Kangen-karyu Salviae Miltiorrhizae Radix Salvianolic acid C Salvianolic acid B
下载PDF
电项针对全脑缺血VD模型大鼠PI3K/AKT/GSK-3β信号通路的影响 被引量:15
11
作者 陈晶 胡新颖 +1 位作者 刘勇 韩鹏 《世界中西医结合杂志》 2018年第2期200-203,288,共5页
目的研究电项针对全脑缺血血管性痴呆(vascular dementia,VD)模型大鼠磷脂酰肌醇-3-激酶/丝氨酸-苏氨酸蛋白激酶/糖原合成酶激酶-3β(Phosphatidylinositol-3 kinase/serine-threonine kinase/glycogen synthase kinase-3β,P13K/AKT/GS... 目的研究电项针对全脑缺血血管性痴呆(vascular dementia,VD)模型大鼠磷脂酰肌醇-3-激酶/丝氨酸-苏氨酸蛋白激酶/糖原合成酶激酶-3β(Phosphatidylinositol-3 kinase/serine-threonine kinase/glycogen synthase kinase-3β,P13K/AKT/GSK-3β)信号通路的影响。方法采用四血管阻断方法制备VD模型大鼠,电项针组取双侧风池穴、供血穴,电针30 min/次,1次/d,治疗14d。采用Y迷宫评价大鼠学习记忆能力;荧光定量PCR(RT-PCR)、Western blot法检测大鼠海马组织中磷酸化蛋白激酶B(phosphorylatedproteinkinaseB,p-AKT)、磷酸化糖原合成酶激酶-3β(Phosphorylated GSK-3β,P-GSK-3β)mRNA和p-AKT、p-GSK-3β蛋白的表达。结果与模型组比较,电项针组可显著提高VD大鼠Y迷宫学习与记忆正确次数(P<0.01)。与模型组比较,电项针组大鼠海马组织中p-AKT、p-GSK-3βmRNA和p-AKT、p-GSK-3β蛋白表达均有不同程度的升高(P<0.01)。结论电项针能够改善VD模型大鼠学习记忆能力,具体机制可能是激活PI3K/AKT/GSK-3β信号通路,发挥抗凋亡作用,起到对缺血海马神经元的保护作用。 展开更多
关键词 电项针 血管性痴呆 全脑缺血 磷脂酰肌醇-3-激酶/丝氨酸-苏氨酸蛋白激酶/糖原合成酶激酶-3β(Phosphatidylinositol-3 kinase/serine-threonine kinase/glycogen synthase kinase-3β P13K/AKT/GSK
下载PDF
糖原合成酶激酶-3及其抑制剂研究进展 被引量:6
12
作者 左明新 陈晓光 《国际药学研究杂志》 CAS 2007年第4期259-262,270,共5页
糖原合成酶激酶-3(glycogen synthase kinase-3,GSK-3)是一种多功能的丝氨酸/苏氨酸蛋白激酶,是细胞内多种信号转导通路中的重要成分,不仅参与细胞内糖代谢过程而且还参与细胞增殖、细胞分化和细胞凋亡等多种重要生理过程。GSK-3活性受... 糖原合成酶激酶-3(glycogen synthase kinase-3,GSK-3)是一种多功能的丝氨酸/苏氨酸蛋白激酶,是细胞内多种信号转导通路中的重要成分,不仅参与细胞内糖代谢过程而且还参与细胞增殖、细胞分化和细胞凋亡等多种重要生理过程。GSK-3活性受多种机制调节,其活性调节异常时可引起多种重大疾病如糖尿病、神经退行性疾病和肿瘤等。GSK-3已成为许多疾病治疗靶点,目前针对GSK-3靶点开发的抑制剂主要是ATP竞争性的小分子GSK-3抑制剂。本文对GSK-3、它与多种重要疾病发生的关系,以及目前开发的GSK-3抑制剂进行了综述。 展开更多
关键词 糖原合成酶激酶-3 糖尿病 阿尔茨海默病 肿瘤 GSK-3抑制剂
下载PDF
脂多糖预处理导致的糖原合成酶激酶-3抑制对肝糖原的影响和机制 被引量:1
13
作者 陈小乐 龚建平 徐发良 《南方医科大学学报》 CAS CSCD 北大核心 2014年第2期201-205,共5页
目的探讨脂多糖预处理时糖原合成酶激酶3(glycogen synthase kinase-3,GSK-3)功能活性的变化及其对肝组织糖原代谢的影响和机制。方法雄性SD大鼠随机分为正常对照、脂多糖预处理和GSK-3抑制剂氯化锂预处理组,分别进行相应处理后再接受... 目的探讨脂多糖预处理时糖原合成酶激酶3(glycogen synthase kinase-3,GSK-3)功能活性的变化及其对肝组织糖原代谢的影响和机制。方法雄性SD大鼠随机分为正常对照、脂多糖预处理和GSK-3抑制剂氯化锂预处理组,分别进行相应处理后再接受大剂量脂多糖(10 mg/kg)攻击以建立脂多糖诱导的急性肝损伤模型;采用PAS染色法观察肝组织糖原聚集,用试剂盒法定量检测肝组织糖原含量,以Western Blot法半定量分析GSK-3的蛋白表达和抑制性磷酸化水平,采用考马斯亮兰比色法测定肝组织钙依赖蛋白酶的活性。结果尽管大剂量脂多糖攻击后各组动物肝组织糖原含量组间比较均无显著差异(P>0.05),但均较攻击前有显著降低(P<0.05),且脂多糖和氯化锂预处理均可导致肝组织糖原含量增加(P<0.05);尽管诱导脂多糖预处理并未改变GSK-3的蛋白表达水平(P>0.05),但导致GSK-3β抑制性磷酸化(P<0.05)和GSK-3α不完全裂解;大剂量脂多糖攻击后肝组织钙依赖蛋白酶活性较前显著升高(P<0.05),但组间比较无显著差异(P>0.05)。结论脂多糖预处理导致GSK-3β抑制性磷酸化和GSK-3α不完全裂解,促进肝组织糖原合成和聚集,但不影响钙依赖蛋白酶活性,有利于增加肝组织糖原储备并可能在遭受大剂量脂多糖攻击时提供能量需求。 展开更多
关键词 糖原合成酶激酶-3 糖原代谢 脂多糖 肝损伤 氯化锂 器官保护 glycogen synthasE kinase-3
下载PDF
GSK-3β抑制剂对糖尿病肾病大鼠肾组织病理、NF-κB及TGF-β1的影响 被引量:6
14
作者 王雪梅 陈海青 《检验医学与临床》 CAS 2020年第23期3448-3452,共5页
目的探讨糖原合成酶激酶-3β(GSK-3β)抑制剂对糖尿病肾病(DN)大鼠肾组织病理、核因子-κB(NF-κB)及转化生长因子-β1(TGF-β1)的影响。方法将36只SD大鼠分为Tz组(DN模型)、Ty组(GSK-3β抑制剂干预)和Wt组(正常大鼠)各12只,观察比较3... 目的探讨糖原合成酶激酶-3β(GSK-3β)抑制剂对糖尿病肾病(DN)大鼠肾组织病理、核因子-κB(NF-κB)及转化生长因子-β1(TGF-β1)的影响。方法将36只SD大鼠分为Tz组(DN模型)、Ty组(GSK-3β抑制剂干预)和Wt组(正常大鼠)各12只,观察比较3组大鼠24 h尿蛋白水平。采用苏木精-伊红(HE)染色观察肾组织结构改变情况,实时荧光定量PCR(RT-qPCR)检测NF-κB mRNA表达水平,免疫组织化学(免疫组化)检测TGF-β1阳性表达情况,Western blot法检测NF-κB、TGF-β1蛋白的表达情况。结果Tz组及Ty组大鼠24 h尿蛋白水平均高于Wt组,Ty组大鼠24 h尿蛋白水平低于Tz组,差异均有统计学意义(P<0.05)。Wt组大鼠肾组织内细胞结构、形态较完整,未观察到增生、肥大的细胞;Tz组大鼠肾小球、系膜基质生长异常,毛细血管管腔、肾小管管腔凹陷、阻塞,伴有间质水肿;Ty组大鼠肾小球和肾小管病变程度较Tz组有明显好转。Tz组、Ty组NF-κB、TGF-β1 mRNA水平高于Wt组,Ty组NF-κB、TGF-β1 mRNA水平低于Tz组,差异均有统计学意义(P<0.05)。免疫组化检测结果显示,Tz组TGF-β1阳性表达最高,Wt组TGF-β1阳性表达最低,Ty组TGF-β1阳性表达较Tz组明显降低,但高于Wt组,差异均有统计学意义(P<0.05)。Tz组及Ty组NF-κB、TGF-β1蛋白表达水平高于Wt组,Ty组NF-κB、TGF-β1蛋白表达水平低于Tz组,差异均有统计学意义(P<0.05)。结论GSK-3β抑制剂能减缓糖尿病肾病大鼠肾损伤程度,降低肾组织中NF-κB和TGF-β1的表达。 展开更多
关键词 糖尿病肾病 糖原合成酶激酶-3β抑制剂 核因子-ΚB 转化生长因子-β1
下载PDF
糖原合成酶激酶-3β在双相情感性精神障碍发病与治疗中的作用研究进展
15
作者 崔颖 薛瑞 +1 位作者 张有志 洪浩 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2016年第4期362-368,共7页
双相情感性精神障碍(BD)是一种严重的精神疾病,具有高患病率、高致残率和高致死率等特点。糖原合成酶激酶-3(GSK-3)是普遍存在于真核细胞内的一种多功能丝氨酸/苏氨酸蛋白激酶,其作用主要包括调节糖原的合成代谢、细胞的分化与增殖以及... 双相情感性精神障碍(BD)是一种严重的精神疾病,具有高患病率、高致残率和高致死率等特点。糖原合成酶激酶-3(GSK-3)是普遍存在于真核细胞内的一种多功能丝氨酸/苏氨酸蛋白激酶,其作用主要包括调节糖原的合成代谢、细胞的分化与增殖以及基因的表达。它参与多条细胞信号传导通路,通过磷酸化调节细胞内许多信号蛋白、结构蛋白和转录因子,进而影响神经元的存活及可塑性。从基因多态性和临床研究发现,GSK-3β可能与BD发生相关。作为GSK-3β抑制剂,锂盐是一种有效的BD治疗药物,以GSK-3β为靶标研发的小分子抑制剂也是BD治疗的热点。综上所述,GSK-3β可能是治疗BD的潜在靶标。 展开更多
关键词 双相情感性精神障碍 糖原合成酶激酶-3 靶标 锂盐 小分子抑制剂
下载PDF
糖原合成酶激酶-3抑制剂在骨质疏松性疾病治疗中的作用研究进展
16
作者 李理 李百川 +3 位作者 王仁崇 唐经励 覃永保 李兵 《中国骨质疏松杂志》 CAS CSCD 北大核心 2016年第9期1188-1194,共7页
骨质疏松症是一种全身性代谢性疾病,其主要特征为骨密度降低,易引发骨质疏松性骨折等疾病。糖原合成酶激酶-3抑制剂能够抑制糖原合成酶激酶-3活性,从而促进Wnt信号转导通路及其下游基因、蛋白的表达,主要通过促进骨髓间充质干细胞、成... 骨质疏松症是一种全身性代谢性疾病,其主要特征为骨密度降低,易引发骨质疏松性骨折等疾病。糖原合成酶激酶-3抑制剂能够抑制糖原合成酶激酶-3活性,从而促进Wnt信号转导通路及其下游基因、蛋白的表达,主要通过促进骨髓间充质干细胞、成骨细胞增殖和分化的同时抑制破骨细胞活性,共同调节骨细胞微环境来实现对骨质疏松性疾病的治疗。现就糖原合成酶激酶-3抑制剂在骨质疏松性疾病治疗过程中的作用研究进展做一综述。 展开更多
关键词 骨质疏松症 糖原合成酶激酶-3抑制剂 WNT信号转导通路
下载PDF
糖原合成激酶3:一个治疗阿尔采末病潜在的药物新靶点 被引量:6
17
作者 李宁 刘耕陶 《中国药理学通报》 CAS CSCD 北大核心 2007年第12期1544-1548,共5页
糖原合成激酶3(GSK3)是普遍存在于细胞内的一种丝/苏氨酸蛋白激酶,其活性受到磷酸化、结合蛋白、细胞内定位等机制的调节。GSK3底物众多,其功能与细胞的存活与凋亡,结构与能动性以及细胞内众多信号传导通路密切相关。GSK3的异常表达与... 糖原合成激酶3(GSK3)是普遍存在于细胞内的一种丝/苏氨酸蛋白激酶,其活性受到磷酸化、结合蛋白、细胞内定位等机制的调节。GSK3底物众多,其功能与细胞的存活与凋亡,结构与能动性以及细胞内众多信号传导通路密切相关。GSK3的异常表达与阿尔采末病(AD)的发病机制、病理表现及治疗有着密切的关系。这为GSK3抑制剂开发成为治疗AD的药物提供了可能。GSK3已成为治疗AD药物作用的一个重要的潜在的靶点。 展开更多
关键词 糖原合成激酶3 GSK3抑制剂 阿尔采末病 靶向药物
下载PDF
基于中草药活性成分的GSK-3β抑制剂的分子模拟 被引量:3
18
作者 唐文强 张静晓 张丽雷 《天然产物研究与开发》 CAS CSCD 北大核心 2018年第12期2070-2076,共7页
使用分子对接和分子动力学方法,研究了一类中草药活性成分抑制糖原合成酶激酶-3β(GSK-3β)的机理。结果表明:筛选出的芦丁、杨酶酮、二氢丹参酮I和人参皂苷Rb1能够与GSK-3β良好地结合,其中芦丁、杨酶酮和二氢丹参酮I主要结合于GSK-3β... 使用分子对接和分子动力学方法,研究了一类中草药活性成分抑制糖原合成酶激酶-3β(GSK-3β)的机理。结果表明:筛选出的芦丁、杨酶酮、二氢丹参酮I和人参皂苷Rb1能够与GSK-3β良好地结合,其中芦丁、杨酶酮和二氢丹参酮I主要结合于GSK-3β的ATP结合口袋区域,人参皂苷Rb1主要结合于GSK-3β的T-loop区域,配体和蛋白之间形成的氢键的数目和存活率是影响结合能力的主要因素,氢键的形成主要取决于配体中的含氧和含氮基团。基于这些有效成分进行结构设计可能获得GSK-3β的高效抑制剂。 展开更多
关键词 糖原合成酶激酶-3抑制剂 中药活性成分 分子对接 分子模拟
下载PDF
Altered Wnt Signaling Pathway in Cognitive Impairment Caused by Chronic Intermittent Hypoxia: Focus on Glycogen Synthase Kinase-3β and β-catenin 被引量:14
19
作者 Yue-Ying Pan Yan Deng +4 位作者 Sheng Xie Zhi-Hua Wang YuWang Jie Ren Hui-Guo Liu 《Chinese Medical Journal》 SCIE CAS CSCD 2016年第7期838-845,共8页
Background: Cognitive impairment is a severe complication caused by obstructive sleep apnea (OSA). The mechanisms of causation are still unclear. The Wntβ-catenin signaling pathway is involved in cognition, and ab... Background: Cognitive impairment is a severe complication caused by obstructive sleep apnea (OSA). The mechanisms of causation are still unclear. The Wntβ-catenin signaling pathway is involved in cognition, and abnormalities in it are implicated in neurological disorders. Here, we explored the Wntβ-catenin signaling pathway abnormalities caused by chronic intermittent hypoxia (CIH), the most characteristic pathophysiological component of OSA. Methods: We divided 32 4-week-old male C57/BL mice into four groups of eight each: a CIH + normal saline (NS) group, CIH + LiCI group, sham CIH + NS group, and a sham CIH + LiCI group. The spatial learning performance of each group was assessed by using the Morris water maze (MWM). Protein expressions of glycogen synthase kinase-β (GSK-β) and β-catenin in the hippocampus were examined using the Western blotting test. EdU labeling and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling staining methods were used, respectively, to determine the proliferation and apoptosis of neurons in the hippocampal dentate gyrus region. Results: Mice exposed to CIH showed impaired spatial learning performance in the MWM, including increased mean escape latencies to reach the target platform, decreased mean times passing through the target platform and mean duration in the target quadrant. The GSK-313 activity increased, and expression of β-catenin decreased significantly in the hippocampus of the CIH-exposed mice. Besides, CIH significantly increased hippocampal neuronal apoptosis, with an elevated apoptosis index. Meanwhile, LiCI decreased the activity of GSK-β and increased the expression of β-catenin and partially reversed the spatial memory deficits in MWM and the apoptosis caused by CIH. Conclusions: Wntβ-catenin signaling pathway abnormalities possibly play an important role in the development of cognitive deficits among mice exposed to CIH and that LiCI might attenuate CIH-induced cognitive impairment via Wntβ-catenin signaling pathway. 展开更多
关键词 Β-CATENIN Chronic Intermittent Hypoxia Cognition glycogen synthase kinase-3β Hippocampus Obstructive SleepApnea
原文传递
基于调控Calpain/GSK-3β信号通路对抑制大鼠酒精性心肌病心肌细胞凋亡的研究 被引量:1
20
作者 王檬 张洁 赵继义 《中国循证心血管医学杂志》 2022年第11期1371-1375,共5页
目的探讨特异性的抑制Calpain能否通过干预Calpain/GSK-3β信号通路降低酒精致大鼠心肌细胞凋亡。方法100只雄性Wistar大鼠随机分成生理盐水对照组(n=10)、酒精组(n=30)、酒精+Calpain-1抑制剂(ALLN)组(n=30)、酒精+二甲基亚砜溶剂(DMSO... 目的探讨特异性的抑制Calpain能否通过干预Calpain/GSK-3β信号通路降低酒精致大鼠心肌细胞凋亡。方法100只雄性Wistar大鼠随机分成生理盐水对照组(n=10)、酒精组(n=30)、酒精+Calpain-1抑制剂(ALLN)组(n=30)、酒精+二甲基亚砜溶剂(DMSO)组(n=30)。造模成功后分别通过心脏超声、HE染色、电镜、TUNEL检测、免疫组化染色法及Western blot法检测各组大鼠心肌细胞中Calpain-1、GSK-3β(H-76)、caspase-9 p10、caspase-3 p17的表达情况。结果与对照组相比,酒精组、酒精+ALLN组、酒精+DMSO组大鼠心脏左室舒张末期内径(LVDD)增大,左室后壁舒张末期厚度(LVPWD)增厚(P<0.05),各组大鼠左室射血分数(LVEF)、左室短轴缩短率(LVFS)均位于正常范围(P>0.05)。酒精组心肌纤维排列紊乱,结构消失,心肌细胞固缩,细胞间质水肿,可见大量炎性细胞浸润,线粒体肿胀,酒精组及酒精+ALLN组心肌细胞凋亡率增加(P<0.05),酒精组Calpain-1、GSK-3β(H-76)、caspase-9 p10、caspase-3 p17蛋白表达水平上调(P<0.05)。酒精+ALLN组与酒精组相比,LVDD略小,LVPWD相对稍薄(P<0.05),病理改变较酒精组减轻,心肌细胞凋亡明显减少(P<0.05),Calpain-1、GSK-3β(H-76)、caspase-9 p10、caspase-3 p17蛋白表达水平下调(P<0.05)。结论大量酒精摄入可致大鼠早期酒精性心肌病模型中心肌细胞凋亡水平升高;Calapin-1抑制剂具有降低酒精诱导的心肌细胞凋亡的保护效应,其机制可能与Calpain对GSK-3β的片段化导致其活性增高,上调凋亡相关蛋白的表达有关。 展开更多
关键词 酒精性心肌病 凋亡 Calpain 1抑制剂 糖原合酶激酶-3Β 大鼠
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部